يحاول ذهب - حر

WHEAT, PADDY ROOTS RUN DEEP IN PUNJAB

February 27, 2024

|

Business Standard

As Centre proposes purchase of alternative crops at MSP, a look at why Punjab farmers are reluctant to diversify

- SANJEEB MUKHERJEE

WHEAT, PADDY ROOTS RUN DEEP IN PUNJAB

A few days ago, a central team of ministers held out a carrot to protesting farmers to break the stalemate in talks.

They proposed to purchase the entire lot of masoor, urad, arhar, maize and cotton over the next five years at minimum support price (MSP) under a contractual agreement.

The purchases will be made through the National Agricultural Cooperative Marketing Federation of India, the National Cooperative Consumers' Federation of India and the Cotton Corporation of India.

And the sellers would be farmers who diversify from wheat and paddy.

Whether the purchases will be limited to just that cohort or extended even to those who have been always cultivating the three pulses, maize and cotton is open to interpretation.

The proposal, according to experts, is directed towards farmers from Punjab and Haryana who are at the forefront of the current agitation that has a cry for MSP at its core.

This, however, is not the first time an attempt is being made to nudge farmers of these two crucial agrarian states from paddy and wheat towards other crops-particularly pulses and maize.

None of the efforts has led to any largescale diversification yet. Paddy and wheat continue to overlay the farmlands of Punjab and Haryana.

"To me, one big reason why farmers of Punjab have so far not shifted from wheat and paddy to any other crop in a big way is that no serious attempts have been made to wean them away from the two," says RS Ghuman, professor of eminence at Amritsar-based Guru Nanak Dev University.

Wheat is a "natural" crop for ab, but the p em lies with paddy, which is not consumed much in the state, he adds.

المزيد من القصص من Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size